Premium
NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE ( MRD ) MONITORING IN MANTLE CELL AND FOLLICULAR LYMPHOMA: THE TARGETED LOCUS AMPLIFICATION ( TLA ) NGS STRATEGY
Author(s) -
Ferrero S.,
Genuardi E.,
Klous P.,
Drandi D.,
Mantoan B.,
Monitillo L.,
Barbero D.,
Yilmaz M.,
Cattellino F.,
Vasta M.,
Cavallo F.,
Cortelazzo S.,
Vitolo U.,
Luminari S.,
Federico M.,
Boccadoro M.,
Splinter E.,
Ladetto M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_3
Subject(s) - minimal residual disease , mantle cell lymphoma , follicular lymphoma , locus (genetics) , biology , molecular marker , microbiology and biotechnology , gene , cancer research , lymphoma , genetics , leukemia , immunology